HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-058 from the NIH Guide for Grants and Contracts. As part of the NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated FOAs to create the HEAL Data2Action (HD2A) Program, a coordinated effort to promote the synthesis and real-world application of existing data to improve epidemiology and guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will improve the quality, timeliness, accessibility and usefulness of data for epidemiology and service delivery in each of the...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2022 Category: Research Source Type: funding
HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
Funding Opportunity RFA-DA-23-057 from the NIH Guide for Grants and Contracts. As part of the NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated RFAs to create the HEAL Data2Action (D2A) Program, a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS Overdose Prevention Strategy: primary prevention, ha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2022 Category: Research Source Type: funding
Support for 988 Tribal Response Cooperative Agreements
Resources to improve response to 988 crisis contacts (including calls, chats, and texts) originating in tribal communities and/or activated by American Indians/Alaskan Natives. Geographic coverage: Nationwide -- Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - September 9, 2022 Category: American Health Source Type: funding
HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required)
Funding Opportunity RFA-DA-23-048 from the NIH Guide for Grants and Contracts. NIH is issuing this Funding Opportunity Announcement (FOA) in response to the declared public health emergency issued by the Secretary, HHS, for the national opioid crisis. This research is part of the Helping to End Addiction Long-term (HEAL) Prevention Initiative, a portfolio of research focused on the prevention of opioid misuse and opioid use disorder funded under NIHs HEAL Initiative. The National Institute on Drug Abuse (NIDA) seeks to address the urgency and magnitude of the opioid crisis by developing and testing new or adapted interv...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 26, 2022 Category: Research Source Type: funding
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)
Funding Opportunity RFA-DA-23-051 from the NIH Guide for Grants and Contracts. In April 2018, the National Institutes of Health (NIH) launched the Helping to End Addiction Long-term Initiative or HEAL Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. Through this initiative, the National Institute on Drug Abuse, in partnership with other NIH Institutes, Centers, and Offices, requests applications for studies designed to develop and test interventions to prevent opioid misuse, opioid use disorder, and co-occurring conditionsby intervening on soc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 13, 2022 Category: Research Source Type: funding
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Optional)
Funding Opportunity RFA-DA-23-045 from the NIH Guide for Grants and Contracts. The need to rapidly develop methods to assess the prevalence / health impact of emerging illicit drugs has never been greater. Illicit chemists are marketing potent drugs of abuse taken from deep wells of scientific and patent literature, which we can expect to continue to yield new drugs for many years. Over the last few years, fentanyl/fentalogs (fentanyl-related opioids) have flooded the illicit opioid market, which has complicated patient stabilization / harm reduction, and caused mortality rates to skyrocket. Even understanding the drugs...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2022 Category: Research Source Type: funding
Supporting Vulnerable At-Risk Youth and Youth Transitioning Out of Foster Care
Funding for pilot demonstration projects to develop, implement, and build replicable treatment models for residential-based innovative care, treatment, and services for adolescents and youth transitioning out of foster care who have experienced a history of foster care involvement, child poverty, child abuse or neglect, human trafficking, juvenile justice involvement, substance use or misuse, or gang involvement. The program has an interest in providing services for youth in rural areas. Geographic coverage: Nationwide -- Office of Juvenile Justice Delinquency Prevention, U.S. Department of Justice (Source: Funding opportu...
Source: Funding opportunities via the Rural Health Information Hub - July 1, 2022 Category: American Health Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Notice NOT-DA-22-070 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2022 Category: Research Source Type: funding
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-052 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research projects. The d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 13, 2022 Category: Research Source Type: funding
Cooperative Agreements for Innovative Community Crisis Response Partnerships
Funding to create or enhance existing mobile crisis response teams to divert adults, children, and youth experiencing mental health crises from law enforcement in high-need communities. A high-need community is one where mobile crisis services are absent or inconsistent, where most mental health crises are responded to by first responders, and/or where first responders are not adequately trained or equipped to diffuse mental health crises. This includes increasing access to licensed/credentialed professionals in rural and remote communities. Geographic coverage: Nationwide -- Substance Abuse and Mental Health Services Admi...
Source: Funding opportunities via the Rural Health Information Hub - May 25, 2022 Category: American Health Source Type: funding
New FY 2021 RCDC Categories and Funding Data are Now Available
NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2021 actual spending data and estimates for FY 2022 and 2023. There are now 309 total RCDC publicly reported categories.
The following are new RCDC topics added in FY 2021:
Celiac Disease
Coronaviruses Diagnostics and Prognostics
Coronaviruses Disparities and At-Risk Populations
Coronaviruses Therapeutics and Interventions
Coronaviruses Vaccines
Dissemination and Implementation Research
Lymphatic Research
Lymphedema
Telehealth
Tickborne Diseases
There were also several existing RCDC categories that were renamed, including:
A...
Source: NIH Extramural Nexus - May 23, 2022 Category: Research Authors: NIH Staff Tags: New Resources NIH funding RCDC Source Type: funding
Asian American, Native Hawaiian, and Pacific Islander Behavioral Health Center of Excellence
Grant to establish a Center of Excellence to provide training and technical assistance and develop and disseminate culturally informed, evidence-based information to advance the behavioral health equity of Asian American, Native Hawaiian, and Pacific Islander communities. Geographic coverage: Nationwide -- Substance Abuse and Mental Health Services Administration (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 10, 2022 Category: American Health Source Type: funding
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
Funding Opportunity PAR-22-182 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adher...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2022 Category: Research Source Type: funding
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
Funding Opportunity PAR-22-183 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adher...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2022 Category: Research Source Type: funding
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-040 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research projects. The d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2022 Category: Research Source Type: funding
